Effect of the co-administration of phenobarbital, quercetin and mancozeb on nitrosomethylurea-induced pancreatic tumors in rats

Food and Chemical Toxicology

Volumn 44, Issue 12, 2006, Pages 2101-2105

  Valentich, M A ^a   Eynard, A R ^a   Barotto, N N ^a   Diaz M P ^a   Bongiovanni, G A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Drug drug interaction; Mancozeb; Nitrosomethylurea; Pancreatic carcinogenesis model; Phenobarbital; Quercetin

Indexed keywords

CYTOCHROME P450; MANCOZEB; METHYLNITROSOUREA; PHENOBARBITAL; QUERCETIN; SODIUM CHLORIDE;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSPLASIA; FEMALE; LACTATION; MALE; NONHUMAN; PANCREAS TUMOR; PREGNANCY; RAT; WEANING;

ALKYLATING AGENTS; ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; CARCINOMA IN SITU; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FUNGICIDES, INDUSTRIAL; HYPERPLASIA; MANEB; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; METHYLNITROSOUREA; PANCREATIC NEOPLASMS; PHENOBARBITAL; PREGNANCY; QUERCETIN; RATS; RATS, WISTAR; ZINEB;

ANIMALIA;

EID: 33749866125     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.07.013     Document Type: Article

References (28)

1. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 107 (1977) 1340-1348
2. Armijo J.A., Sanchez M.B., Campos C., and Adin J. The interactions of antiepileptic drugs in oncology practice. Rev. Neurol. 42 (2006) 681-690
3. Barotto N.N., Lopez C.B., Eynard A.R., Fernandez Zapico M.E., and Valentich M.A. Quercetin enhances pretumorous lesions in the NMU model of rat pancreatic carcinogenesis. Cancer Lett. 129 (1998) 1-6
4. Belpoggi F., Soffritti M., Guarino M., Lambertini L., Cevolani D., Maltoni C., et al. Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats. Ann. N.Y. Acad. Sci. 982 (2002) 123-136
5. Foster J.R., Idle J.R., Hardwick J.P., Bars R., Scott P., Braganza J.M., et al. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J. Pathol. 169 (1993) 457-463
6. Guengerich F.P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48 (1988) 2946-2954
7. Guengerich F.P. Cytochromes P450, drugs, and diseases. Mol. Intervent. 3 (2003) 194-204
8. Hariparsad N., Sane R.S., Strom S.C., and Desai P.B. In vitro methods in human drug biotransformation research: implications for cancer chemotherapy. Toxicol. In Vitro 20 (2006) 135-153
9. IARC, International Agency for Research on Cancer. Overall evaluations of carcinogenicity. An updating of IARC monographs. IARC Monographs on Evaluation of Carcinogenic Risk to Humans Vol. 1-42 (Suppl. 7) (1987), IARC, Lyons, France
10. Kang I.H., Kim H.J., Oh H., Park Y.I., and Dong M.S. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5. Mutat. Res. 545 (2004) 37-47
11. Kwan P., and Brodie M.J. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45 (2004) 1141-1145
12. Leeder J.S. Phenobarbital and other barbiturates: interactions with other drugs. In: Levy R.H., Mattson R.H., Meldrum B.S., et al. (Eds). Antiepileptic drugs. Fifth specific protective effect observed to PB is in agreement to ed (2002), Lippincott Williams & Wilkins, Philadelphia 504-513
13. Longnecker D.S., Chandar N., Sheahan D.G., Janosky J.E., and Lombardi B. Preneoplastic and neoplastic lesions in the pancreas of rats fed choline-devoid or choline-supplemented diets. Toxicol. Pathol. 19 (1991) 59-65
14. McCullagh P., and Nelder J. Generalized Linear Models. second ed. (1989), Chapman and Hall, London
15. Monis B., and Valentich M.A. Promoting effects of mancozeb on pancreas of nitrosomethylurea-treated rats. Carcinogenesis 14 (1993) 929-933
16. Monis B., Valentich M.A., Urrutia R., and Rivolta M. Multicentric focal acinar cell hyperplasia and hepatocyte-like cell metaplasia are induced by nitrosomethylurea in rat pancreas. Int. J. Pancreatol. 8 (1991) 119-131
17. Nebbia C., Dacasto M., Topi B., Burdino E., and Ugazio G. Zinc ethylene-bis-dithiocarbamate (Zineb)-mediated inhibition of monooxygenases and lipid peroxidation in bovine liver microsomes. Vet. Hum. Toxicol. 39 (1997) 272-275
18. Nebert D.W. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5 (1991) 1203-1214
19. Ohhira S., Matsui H., and Watanabe K. Effects of pretreatment with cytochrome P450 inducers, especially phenobarbital on triphenyltin metabolism and toxicity in hamsters. Toxicology 137 (1999) 151-159
20. Ordonez N.G. Pancreatic acinar cell carcinoma. Adv. Anat. Pathol 8 (2001) 144-159
21. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistic, 2002. CA Cancer J. Clin. 55 (2005) 74-108
22. Peraino C., Fry R.J.M., and Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31 (1971) 1506-1512
23. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol. 61 (2006) 246-255
24. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. A comprehensive list of substrates, inhibitors, and inducers of human P450s. Drug Metabol. Rev. 34 (2002) 83-448
25. Risch H.A. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J. Natl. Cancer Inst. 95 (2003) 948-960
26. Sanders S., and Thorgeirsson S.S. Phenobarbital promotes liver growth in c-myc/TGF-α transgenic mice by inducing hypertrophy and inhibiting apoptosis. Carcinogenesis 20 (1999) 41-49
27. Singh G., Driever P.H., and Sander J.W. Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 128 (2005) 7-17
28. Waxman D.J., and Chang T.K.H. Hormonal regulation of liver cytochrome P450 enzymes. In: Ortiz de Montellano P.R. (Ed). Cytochrome P450: Structure, Mechanism, and Biochemistry. second ed. (1995), Plenum Press, New York 391-417